OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neural Transmission is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Facets of movement disorders– a tribute to Heinz Reichmann	112
Proteinopathies: molecular mechanisms and diagnostic perspectives	76
Movement disorders associated with diarrhoea	67
Contrasting features between Tourette syndrome and secondary tic disorders	64
Alterations in metabolites in the anterior cingulate cortex and thalamus and their associations with pain and empathy in patients with chronic mild pain: a preliminary study	63
Neuromodulation of excitation-inhibition balance in dementia with lewy bodies: a translational framework	63
Celebrating the career of professor Zdravko Lacković: a life in neuroscience, pharmacology, and discovery	62
Eye movement study in essential tremor patients and its clinical correlates	60
A wearable device-enabled therapeutic approach to improve joint attention in autism spectrum disorder: a prospective pilot study	59
Stress enhances heartbeat-evoked potentials, independent of continuous or intermittent theta burst stimulation of the interoceptive brain network targeting the right supramarginal gyrus: a preliminary	53
Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson’s disease	50
Sitagliptin attenuates L-dopa-induced dyskinesia by regulating mitochondrial proteins and neuronal activity in a 6-OHDA-induced mouse model of Parkinson’s disease	48
Dopamine agonists in the treatment of Parkinson's disease: the show must go on	48
A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response:	46
Current perspectives on brain circuits involved in food addiction-like behaviors	44
Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?	42
Distinct gait dimensions are modulated by physical activity in Parkinson's disease patients	42
Cholinergic neurotransmission in the brain of streptozotocin-induced rat model of sporadic Alzheimer’s disease: long-term follow up	41
Pathogenesis of Parkinson’s disease: from hints from monogenic familial PD to biomarkers	40
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes	37
Unravelling head tremor mechanisms: insights from speech analysis in essential tremor and cervical dystonia	34
Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey	33
Understanding cognitive features of cervical dystonia: application of the cerebellar cognitive affective syndrome scale (CCAS-S)	33
Botulinum toxin for chronic migraine	32
Reduced vagal activity in borderline personality disorder is unaffected by intranasal oxytocin administration, but predicted by the interaction between childhood trauma and attachment insecurity	32

Non motor Parkinson: subtypes, biomarkers, stepped care and a journal!	31
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016	30
Association between autonomic dysfunction with motor and non-motor symptoms in patients with Parkinson's disease	29
Bradykinesia and rigidity modulated by functional connectivity between the primary motor cortex and globus pallidus in Parkinson’s disease	28
Unusual delayed and prolonged arm weakness and atrophy following botulinum toxin injection for musician’s cramp: case report	28
Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer’s disease therapy	28